Are you Dr. Kennedy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 87 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1100 Walnut St
MOB 5TH floor
Philadelphia, PA 19107Phone+1 215-955-6750Fax+1 215-923-8222- Is this information wrong?
Summary
- Dr. Eugene Kennedy, MD is a general surgeon in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Louisiana, and Maryland. He is affiliated with Thomas Jefferson University Hospital.
Education & Training
Johns Hopkins UniversityResidency, Surgery, 1996 - 2004
Virginia Commonwealth University School of MedicineClass of 1996
Certifications & Licensure
PA State Medical License 2005 - 2024
MD State Medical License 1999 - 2008
LA State Medical License 2005 - 2007
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy Start of enrollment: 2006 May 25
- Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer Start of enrollment: 2008 Sep 01
- An Evaluation of a New Technique Utilizing a Biologic Glue and Tissue Patch to Seal the Cut Edge of the Pancreas Following Removal of the Tail of the Pancreas Start of enrollment: 2008 Aug 01
Publications & Presentations
PubMed
- 32 citationsInhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunityMadhav D. Sharma, Rafal Pacholczyk, Huidong Shi, Zuzana Berrong, Yousef Zakharia, Austin Greco, Chang Sheng S. Chang, Sudharshan Eathiraj, Eugene P. Kennedy, Thomas Ca...> ;Immunity. 2021 Oct 12
- 38 citationsPhase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma.Yousef Zakharia, Robert R. McWilliams, Olivier Rixe, Joseph J. Drabick, Montaser Shaheen, Kenneth F. Grossmann, Ravindra Kolhe, Rafal Pacholczyk, Ramses F. Sadek, Luci...> ;Journal for Immunotherapy of Cancer. 2021 Jun 11
- 19 citationsEffect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial.Veronica Mariotti, Hyo S. Han, Roohi Ismail-Khan, Shou-Ching Tang, Patrick M. Dillon, Alberto J. Montero, Andrew Poklepovic, Susan A. Melin, Nuhad K. Ibrahim, Eugene P...> ;JAMA Oncology. 2021 Jan 1
- Join now to see all
Press Mentions
Summary of NewLink Genetics Corporation (NASDAQ:NLNK) Ratings as of Dec 17, 2018December 17th, 2018
Update Confirms Benefit of Pembrolizumab plus Indoximod in MelanomaSeptember 7th, 2017
Professional Memberships
- Member
- Member
Hospital Affiliations
Thomas Jefferson University HospitalPhiladelphia, Pennsylvania
